EU approves upscaling of Moderna vaccine in US production facilities

The EMA CHMP has given the stamp of approval for US medical company Moderna to increase its production of the active substance in the firm's coronavirus vaccine in two of the company's US facilities.

Photo: Dado Ruvic/Reuters/Ritzau Scanpix

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has given the green light for the US pharmaceutical company Moderna to increase the production of the active substance in the firm's covid-19 vaccine known as Spikevax in two of the firm's factories on US soil.

The EMA states this in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs